V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Non-neutralizing IgG to the V1V2 loop of HIV-1 gp120 correlates with a decreased risk of HIV-1 infection but the mechanism of protection remains unknown. This V1V2 IgG correlate was identified in RV144 Thai trial vaccine recipients, who were primed with a canarypox vector expressing membrane-bound g...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Lautaro G., Martinez, David R., deCamp, Allan C., Pinter, Abraham, Berman, Phillip W., Francis, Donald, Sinangil, Faruk, Lee, Carter, Greene, Kelli, Gao, Hongmei, Nitayaphan, Sorachai, Rerks-Ngarm, Supachai, Kaewkungwal, Jaranit, Pitisuttithum, Punnee, Tartaglia, James, O’Connell, Robert J., Robb, Merlin L., Michael, Nelson L., Kim, Jerome H., Gilbert, Peter, Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498072/
https://www.ncbi.nlm.nih.gov/pubmed/28678869
http://dx.doi.org/10.1371/journal.pone.0180720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498072/
https://www.ncbi.nlm.nih.gov/pubmed/28678869
http://dx.doi.org/10.1371/journal.pone.0180720

Ejemplares similares